Skip to main content
European Commission logo print header

Advanced spectroscopic hemogram for personalized care against live threatening infections using an integrated chip-assisted bio-photonic system

Project description


Heterogeneous Integration and take-up of of Key Enabling Technologies for Components and Systems

Life threatening infectious diseases and sepsis are worldwide problems with high mortalities. In order to select optimal treatments for the highly heterogeneous group of sepsis patients and to reduce costs, novel multiplexed tools that better characterize the patient and its specific immune response are highly desired.In the novel project "HemoSpec" a multidisciplinary team develops - driven by the demands of the two clinical partners - a highly innovative technological platform for early, fast and reliable medical diagnosis of infectious diseases using only minimal amounts of patient's blood. HemoSpec combines in one device three key enabling technologies: automated microfluidic sample handling with integrated holographic blood count, simultaneous multiplex fluorescence biomarker sensing and detailed Raman spectroscopic leukocyte characterization. In each of the technologies experts in the consortium can build on previous knowledge and will improve system characteristics for higher performance and functionality. Strong focus will be on the miniaturization, optimization as well as on the integration of the individual parts. One common user interface, common data storage and analysis software will make the dense information from HemoSpec available to the clinical enduser in a single working step. The integrated multiplex analysis of HemoSpec will be validated in two clinics in two countries specialized on hospital-acquired and community-acquired sepsis, respectively.Strong industrial participation (four companies from four different countries) spanning the portfolio from biomarker supply to spectrometer companies up to software integrators assures ultimate exploitation of the innovative developments and the final device on the market leading to enhanced European market leadership in the field of medical diagnosis. Ultimately, this can help to administer the right therapy to the right patient at the right time reducing the costs in the health care sector.

Call for proposal

FP7-ICT-2013-10
See other projects for this call

Coordinator

LEIBNIZ-INSTITUT FUER PHOTONISCHE TECHNOLOGIEN E.V.
EU contribution
€ 962 072,00
Address
Albert Einstein strasse 9
07745 Jena
Germany

See on map

Region
Thüringen Thüringen Jena, Kreisfreie Stadt
Activity type
Research Organisations
Administrative Contact
Gabriele Hamm (Ms.)
Links
Total cost
No data

Participants (7)